Key clinical point: Vaccination was effective despite the expected decrease in immunological response during MM therapy.
Major finding: The absolute risk reduction of pneumonias in patients receiving PCV13 vaccination was
Study details: Prospective study of 18 adult patients who were vaccinated with PCV13, compared with 18 control-matched patients from 2017 to 2020.
Disclosures: The authors reported that they had no relevant disclosures.
Stoma I et al. Vaccine. 2020 May 14; doi.org/10.1016/j.vaccine.2020.05.024.